Part 2 of Q&A with CLSA CEO Sara Radcliffe

Note: Ahead of the BIO Investor Forum in San Francisco, Big3Bio is combining its Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe (part 1 here) with mendelspod. This video feature will run with chapter updates every day of this week. Chapter 1: CLSA - California’s first statewide trade group for biotech   Chapter [...]

October 12th, 2015|

Big3Bio Q&A: CLSA CEO Sara Radcliffe (Part 1)

Note: Ahead of the AdvaMed conference next week in San Diego and the BIO Investor Forum in San Francisco two weeks later, Big3Bio has a two-part Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe – the first part is today through Friday (two questions a day), a week prior to AdvaMed, and the second part [...]

September 28th, 2015|

QB3’s Quick Pitch Competition

QB3 held its first annual tech showcase, QB3 Quick Pitch, Tuesday night to a full house at Byers Auditorium. After a keynote from Corey Goodman of venBIO, 12 companies pitched their solutions to judges and the audience. From an SF Business Times article prior to the event: "The 12 companies for the first workshop, selected from [...]

December 10th, 2014|

Curium Launches at UCSF with Bay Area Entrepreneurs Panel

By Dr. Karen Ring, Big3Bio Events Correspondent With an overabundance of PhD’s in an environment of dwindling academic jobs, graduate students and postdocs are opting for less traditional pathways to achieve scientific success -- this transition from academic to entrepreneur was the topic of discussion at the launch of Curium last night at UCSF. Curium [...]

October 28th, 2014|

Special Feature: Q&A With Menghis Bairu, CEO of Serenus Biotherapeutics

Dr. Menghis Bairu is Founder, Chairman, and CEO of Sereneus Biotherapeutics, a specialty biopharmaceutical bringing innovative therapies to Sub-Saharan African markets. Before founding Serenus, Dr. Bairu concurrently served as EVP, Chief Medical Officer & Head of Global Development at Elan plc and president and CEO of Speranza Therapeutics, Elan’s wholly owned subsidiary formed to develop [...]

June 20th, 2014|